tiprankstipranks
Trending News
More News >
Alembic Pharmaceuticals Limited (IN:APLLTD)
:APLLTD
India Market

Alembic Pharmaceuticals Limited (APLLTD) Financial Statements

Compare
1 Followers

Alembic Pharmaceuticals Limited Financial Overview

Alembic Pharmaceuticals Limited's market cap is currently ₹190.70B. The company's EPS TTM is ₹8; its P/E ratio is 32.69; and it has a dividend yield of 1.13%. Alembic Pharmaceuticals Limited is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is ₹7.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 66.72B₹ 62.29B₹ 56.53B₹ 52.32B₹ 52.76B
Gross Profit₹ 48.79B₹ 22.69B₹ 39.44B₹ 35.09B₹ 37.55B
Operating Income₹ 33.16B₹ 5.76B₹ 4.38B₹ 5.87B₹ 12.97B
EBITDA₹ 10.08B₹ 9.62B₹ 7.11B₹ 9.25B₹ 15.68B
Net Income₹ 5.83B₹ 6.16B₹ 3.42B₹ 5.21B₹ 11.46B
Balance Sheet
Cash & Short-Term Investments₹ 901.00M₹ 1.20B₹ 921.20M₹ 610.90M₹ 2.85B
Total Assets₹ 77.73B₹ 64.46B₹ 61.83B₹ 71.22B₹ 67.09B
Total Debt₹ 12.57B₹ 5.13B₹ 7.22B₹ 7.17B₹ 5.84B
Net Debt₹ 11.67B₹ 3.93B₹ 6.47B₹ 6.56B₹ 4.86B
Total Liabilities₹ 25.83B₹ 16.27B₹ 18.12B₹ 18.84B₹ 16.42B
Stockholders' Equity₹ 51.91B₹ 48.18B₹ 43.70B₹ 52.38B₹ 51.28B
Cash Flow
Free Cash Flow₹ -4.76B₹ 4.76B₹ 2.81B₹ 1.27B₹ 8.04B
Operating Cash Flow₹ 879.70M₹ 8.03B₹ 7.24B₹ 5.52B₹ 14.63B
Investing Cash Flow₹ -5.68B₹ -3.21B₹ -4.48B₹ -3.72B₹ -8.39B
Financing Cash Flow₹ 4.44B₹ -4.38B₹ -2.62B₹ -2.17B₹ -5.97B
Currency in INR

Alembic Pharmaceuticals Limited Earnings and Revenue History

Alembic Pharmaceuticals Limited Debt to Assets

Alembic Pharmaceuticals Limited Cash Flow

Alembic Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis